Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Michael Cannon-Brookes Sells 7,948 Shares of Atlassian Co. (NASDAQ:TEAM) Stock
Atlassian Co. (NASDAQ:TEAM – Get Free Report) CEO Michael Cannon-Brookes sold 7,948 shares of the firm’s stock in a transaction...
Philip Chesley Sells 4,045 Shares of Qorvo, Inc. (NASDAQ:QRVO) Stock
Qorvo, Inc. (NASDAQ:QRVO – Get Free Report) SVP Philip Chesley sold 4,045 shares of the business’s stock in a transaction...
Keysight Technologies, Inc. (NYSE:KEYS) SVP Jeffrey K. Li Sells 4,412 Shares
Keysight Technologies, Inc. (NYSE:KEYS – Get Free Report) SVP Jeffrey K. Li sold 4,412 shares of the firm’s stock in...
William C. Green Acquires 5,269 Shares of Arbor Realty Trust, Inc. (NYSE:ABR) Stock
Arbor Realty Trust, Inc. (NYSE:ABR – Get Free Report) Director William C. Green purchased 5,269 shares of the stock in...
US Trade Deficit Falls to $74 Billion in October
By Naveen Athrappully America’s trade deficit dipped in October from the previous month, with imports and exports falling more than...
Intact Financial (TSE:IFC) Hits New 1-Year High – Time to Buy?
Intact Financial Co. (TSE:IFC – Get Free Report) hit a new 52-week high during mid-day trading on Friday . The...